Why Apellis Pharmaceuticals, Inc. (APLS) Skyrocketed On Monday

By Yahoo! Finance   |   1 month ago
Why Apellis Pharmaceuticals, Inc. (APLS) Skyrocketed On Monday

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) stock surged by 13.05% on Monday to $19.14 after receiving a higher price target from Wells Fargo. The firm raised the target to $29, citing optimism about the company's potential treatment for rare kidney diseases.

Read More

Did you find this insightful?